Serum LincRNA-p21 Expression in Primary Liver Diseases and Liver Metastatic Diseases
ConclusionSerum lincRNA-p21 may serve as a potential biomarker for liver cell damage in patients with hepatitis virus infection, hepatitis B cirrhosis, HBV-related HCC and alcoholic liver disease.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Alcoholism | Cancer | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Pathology | Urology & Nephrology